A randomized trial of pancreatic stent placement and NSAIDs to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis
Not Applicable
- Conditions
- post-endoscopic retrograde cholangiopancreatography pancreatitis
- Registration Number
- JPRN-UMIN000031705
- Lead Sponsor
- Hyogo prefectural Awaji Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
acute pancreatitis,chronic pancreatitis with acute painful exacerbation,peptic ulcer,rectal disease,aspirin-induced asthma,NSAIDs during the preceding 1 week,hypersensitivity to NSAIDs,severe renal dysfunction,pregnant,breast-feeding,inability to provide written informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The occurrence of post ERCP pancreatitis
- Secondary Outcome Measures
Name Time Method